Analystreport

Melinta Therapeutics Inc (NASDAQ: MLNT) had its "sell" rating re-affirmed by analysts at Gabelli.

MELINTA THERAPEUTICS INC  (MLNT) 
Last melinta therapeutics inc earnings: 11/12 04:39 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.melinta.com/investor-relations